As high visfatin levels have been consistently associated with obesity, type 2 diabetes, and the metabolic syndrome [7, 22, 23], we tested whether obesity or type 2 diabetes as a comorbidity at ICU admission impacted visfatin levels. The gene discussed is NAMPT; the disease is type 2 diabetes mellitus.